Putting the Drug Debate into Context: the State of Pharmaceutical Cost Reform in the U.S.
U.S. medical care has experienced huge and unsustainable spending increases—especially in drug prices—for decades. Under the Affordable Care Act, the Obama administration accelerated the value-based care movement to address key spending categories such as hospital and physician care. Value-based purchasing seeks to reduce spending by improving quality and efficiency to address unnecessary costs. Most stakeholders … Continue reading “Putting the Drug Debate into Context: the State of Pharmaceutical Cost Reform in the U.S.”